Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 5, 2007 - Issue 4
Submit an article Journal homepage
104
Views
20
CrossRef citations to date
0
Altmetric
Review

New antiarrhythmic treatment of atrial fibrillation

Gerald V Naccarelli Penn State University Heart and Vascular Institute, The Electrophysiology Program, Penn State University College of Medicine, The Milton S. Hershey Medical Center, 500 University Dr., Room H 1.511, Hershey, PA 17033, USA. [email protected]
,
Deborah L Wolbrette Penn State University Heart and Vascular Institute, The Electrophysiology Program, Penn State University College of Medicine, The Milton S. Hershey Medical Center, 500 University Dr., Room H 1.511, Hershey, PA 17033, USA. [email protected]
,
Soraya Samii Penn State University Heart and Vascular Institute, The Electrophysiology Program, Penn State University College of Medicine, The Milton S. Hershey Medical Center, 500 University Dr., Room H 1.511, Hershey, PA 17033, USA. [email protected]
,
Javier E Banchs Penn State University Heart and Vascular Institute, The Electrophysiology Program, Penn State University College of Medicine, The Milton S. Hershey Medical Center, 500 University Dr., Room H 1.511, Hershey, PA 17033, USA. [email protected]
,
Erica Penny-Peterson Penn State University Heart and Vascular Institute, The Electrophysiology Program, Penn State University College of Medicine, The Milton S. Hershey Medical Center, 500 University Dr., Room H 1.511, Hershey, PA 17033, USA. [email protected]
&
Mario D Gonzalez Penn State University Heart and Vascular Institute, The Electrophysiology Program, Penn State University College of Medicine, The Milton S. Hershey Medical Center, 500 University Dr., Room H 1.511, Hershey, PA 17033, USA. [email protected]
Pages 707-714 | Published online: 10 Jan 2014

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Birgit T Priest & Jeff S McDermott. (2015) Cardiac ion channels. Channels 9:6, pages 352-359.
Read now
Gerald V Naccarelli, Deborah L Wolbrette, Soraya Samii, Javier E Banchs, Erica Penny-Peterson, Robert Stevenson & Mario D Gonzalez. (2008) Vernakalant – a promising therapy for conversion of recent-onset atrial fibrillation. Expert Opinion on Investigational Drugs 17:5, pages 805-810.
Read now

Articles from other publishers (18)

De‐wei Peng, Ying‐yu Lai, Xue‐shan Luo, Xin Li, Chun‐yu Deng, Hui‐ming Guo, Jun‐fei Zhao, Hui Yang, Yang Liu, Zhao‐yu Wang, Yu‐wen Xu, Su‐juan Kuang, Shu‐lin Wu, Yu‐mei Xue & Fang Rao. (2021) Connexin 43 participates in atrial electrical remodelling through colocalization with calcium channels in atrial myocytes. Clinical and Experimental Pharmacology and Physiology 49:1, pages 25-34.
Crossref
Parveen K Garg, Weihua Guan, Sarah Nomura, Natalie Weir, Amy B Karger, Daniel Duprez, Susan R Heckbert & Michael Y Tsai. (2021) Plasma ω-3 and ω-6 PUFA Concentrations and Risk of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis. The Journal of Nutrition 151:6, pages 1479-1486.
Crossref
Alina Scridon & Antoni Martínez-Rubio. 2020. Antiarrhythmic Drugs. Antiarrhythmic Drugs 307 377 .
David A. Garcia. (2012) Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation. Thrombosis Research 129:1, pages 9-16.
Crossref
Gerald V. Naccarelli. 2012. Electrophysiological Disorders of the Heart. Electrophysiological Disorders of the Heart 1159 1166 .
T. Jared Bunch & Bernard J. Gersh. (2010) Rhythm Control Strategies and the Role of Antiarrhythmic Drugs in the Management of Atrial Fibrillation: Focus on Clinical Outcomes. Journal of General Internal Medicine 26:5, pages 531-537.
Crossref
H. Simon, K. Simon Demel, G. Ritscher, O. Turschner & J. Brachmann. (2010) Neue Entwicklungen in der antiarrhythmischen Therapie des VorhofflimmernsNew developments in the antiarrhythmic therapy of atrial fibrillation. Herzschrittmachertherapie + Elektrophysiologie 21:4, pages 212-216.
Crossref
Gerald V. NaccarelliAnne B. Curtis. (2010) Review: Optimizing the Management of Atrial Fibrillation: Focus on Current Guidelines and the Impact of New Agents on Future Recommendations. Journal of Cardiovascular Pharmacology and Therapeutics 15:3, pages 244-256.
Crossref
Stefan Dhein, Anja Hagen, Joanna Jozwiak, Anna Dietze, Jens Garbade, Markus Barten, Martin Kostelka & Friedrich-Wilhelm Mohr. (2009) Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides. Naunyn-Schmiedeberg's Archives of Pharmacology 381:3, pages 221-234.
Crossref
Anja Hagen & Stefan Dhein. 2009. Novel Therapeutic Targets for Antiarrhythmic Drugs. Novel Therapeutic Targets for Antiarrhythmic Drugs 431 460 .
M.-D. Drici. (2009) Les nouveaux médicaments antiarythmiques de la fibrillation auriculaire. Annales de Cardiologie et d'Angéiologie 58, pages S61-S63.
Crossref
Rakesh Gopinathannair, Renee M. Sullivan & Brian Olshansky. (2009) Update on medical management of atrial fibrillation in the modern era. Heart Rhythm 6:8, pages S17-S22.
Crossref
T. S. Han, G. R. Williams & M. P. J. Vanderpump. (2009) Benzofuran derivatives and the thyroid. Clinical Endocrinology 70:1, pages 2-13.
Crossref
Peter WeekeCharlotte AnderssonBente BrendorpChristian Torp-Pedersen. (2008) Vernakalant (RSD1235) in the management of atrial fibrillation: a review of pharmacological properties, clinical efficacy and safety. Future Cardiology 4:6, pages 559-567.
Crossref
Gerald V Naccarelli & Mario D Gonzalez. (2008) Atrial Fibrillation and the Expanding Role of Catheter Ablation: Do Antiarrhythmic Drugs Have a Future?. Journal of Cardiovascular Pharmacology 52:3, pages 203-209.
Crossref
Emily Conway, Simone Musco & Peter R. Kowey. (2008) New Horizons in Antiarrhythmic Therapy: Will Novel Agents Overcome Current Deficits?. The American Journal of Cardiology 102:6, pages 12H-19H.
Crossref
MARC COHEN & GERALD V. NACCARELLI. (2008) Pathophysiology and Disease Progression of Atrial Fibrillation: Importance of Achieving and Maintaining Sinus Rhythm. Journal of Cardiovascular Electrophysiology 19:8, pages 885-890.
Crossref
Yoshihiro Hashimoto. (2008) Research and development strategy of anti-atrial fibrillation agents. Folia Pharmacologica Japonica 131:6, pages 452-456.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.